☆ 4.6 Letter

Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer

JAMA ONCOLOGY (2019)

Get Full Text
Add to Collection

Journal

JAMA ONCOLOGY
Volume 5, Issue 7, Pages 1060-1062

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2019.0869

Keywords

-

Categories

Oncology

Funding

  1. Belgian Foundation Against Cancer [C/2014/227]
  2. Kom op tegen Kanker (Stand up to Cancer)
  3. Flemish Cancer Society [00000000116000000206]
  4. Royal College of Surgeons/Cancer Research UK [C19198/A1533]
  5. Cancer Research Funds of Radiumhemmet through the PCMprogram at KI [163012]
  6. Erling-Persson Family Foundation [4-2689-2016]
  7. Swedish Research Council [K2010-70X-20430-04-3]
  8. Swedish Cancer Foundation [09-0677]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.